Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

RVL Pharmaceuticals plc OSMT

Full chart Compare
Set alert

Price alert · OSMT

All alert types
1.11 +1.11

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-8.04 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.2×
FY 2016: -8.3×FY 2017: -7.8×FY 2018: -3.2×FY 2019: -1.4×FY 2020: -3.2×
FY 2016 5y median -3.2× FY 2020
P/S 1.5×
FY 2016: 1.6×FY 2017: 1.4×FY 2018: 1.3×FY 2019: 1.5×FY 2020: 1.5×
FY 2016 5y median 1.5× FY 2020
P/B 2.8×
FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.9×FY 2019: 3.2×FY 2020: 2.8×
FY 2016 5y median 0.9× FY 2020
P/FCF 17.9×
FY 2016: -5.8×FY 2017: 6.9×FY 2018: 10.5×FY 2019: 12.4×FY 2020: 17.9×
FY 2016 5y median 10.5× FY 2020
EV/EBITDA -7.5×
FY 2016: -79.4×FY 2017: -62.6×FY 2018: -0.8×FY 2019: -10.7×FY 2020: -7.5×
FY 2016 5y median -10.7× FY 2020
EV/Sales 2.0×
FY 2016: 3.0×FY 2017: 2.6×FY 2018: 2.1×FY 2019: 2.3×FY 2020: 2.0×
FY 2016 5y median 2.3× FY 2020
FCF Yield 5.6%
FY 2016: -17.4%FY 2017: 14.6%FY 2018: 9.5%FY 2019: 8.1%FY 2020: 5.6%
FY 2016 5y median 8.1% FY 2020

Profitability

Gross Margin 58.1%
FY 2016: 42.5%FY 2017: 49.1%FY 2018: 48.8%FY 2019: 53.5%FY 2020: 58.1%
FY 2016 5y median 49.1% FY 2020
Operating Margin 1.0%
FY 2016: -1.0%FY 2017: 8.5%FY 2018: 2.2%FY 2019: 1.3%FY 2020: 1.0%
FY 2016 5y median 1.3% FY 2020
Net Margin -44.7%
FY 2016: -19.1%FY 2017: -18.4%FY 2018: -41.5%FY 2019: -112.9%FY 2020: -44.7%
FY 2016 5y median -41.5% FY 2020
ROE -84.8%
FY 2016: -9.0%FY 2017: -10.8%FY 2018: -28.3%FY 2019: -236.2%FY 2020: -84.8%
FY 2016 5y median -28.3% FY 2020
ROIC 0.5%
FY 2016: -0.2%FY 2017: 1.4%FY 2018: 0.8%FY 2019: 0.7%FY 2020: 0.5%
FY 2016 5y median 0.7% FY 2020
ROA -21.5%
FY 2016: -4.3%FY 2017: -5.1%FY 2018: -13.7%FY 2019: -58.5%FY 2020: -21.5%
FY 2016 5y median -13.7% FY 2020

Growth (YoY)

Revenue -25.9%
FY 2016: 0.0%FY 2017: 12.5%FY 2018: 7.3%FY 2019: -9.0%FY 2020: -25.9%
FY 2016 FY 2020
Operating Income -42.8%
FY 2016: 0.0%FY 2017: 1061.3%FY 2018: -72.8%FY 2019: -46.3%FY 2020: -42.8%
FY 2016 FY 2020
EPS (diluted) 75.4%
FY 2016: 0.0%FY 2017: -7.1%FY 2018: -130.5%FY 2019: -113.6%FY 2020: 75.4%
FY 2016 FY 2020
Free Cash Flow -51.0%
FY 2016: 0.0%FY 2017: 183.9%FY 2018: -34.4%FY 2019: -11.6%FY 2020: -51.0%
FY 2016 FY 2020

Financial Health

Current Ratio 3.1×
FY 2016: 0.8×FY 2017: 0.9×FY 2018: 1.5×FY 2019: 2.3×FY 2020: 3.1×
FY 2016 5y median 1.5× FY 2020
Quick Ratio 2.8×
FY 2016: 0.6×FY 2017: 0.8×FY 2018: 1.3×FY 2019: 2.0×FY 2020: 2.8×
FY 2016 5y median 1.3× FY 2020
Debt / Equity 2.3×
FY 2016: 0.7×FY 2017: 0.8×FY 2018: 0.7×FY 2019: 2.4×FY 2020: 2.3×
FY 2016 5y median 0.8× FY 2020
Net Debt / EBITDA -2.2×
FY 2016: -37.3×FY 2017: -28.2×FY 2018: -0.3×FY 2019: -3.5×FY 2020: -2.2×
FY 2016 5y median -3.5× FY 2020
Interest Coverage 0.1×
FY 2016: -0.1×FY 2017: 0.7×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.1×
FY 2016 5y median 0.2× FY 2020

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2016 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2016 5y median 0.0% FY 2020

Annual · latest fiscal year ends 2020-12-31